Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Brain scans and imaging

Topic: Risk, prevention and care in population studies

ABSTRACT Background Accessing brain magnetic resonance imaging (MRI) can be challenging, especially for underserved patients, which may lead to disparities in neurological diagnosis. Method This mixed‐methods study enrolled adults with one of four neurological disorders: mild cognitive impairment or dementia of the Alzheimer type, multiple sclerosis (MS), Parkinson disease (PD), or stroke. Participants were enrolled at the Massachusetts General Hospital outpatient clinic in Boston (01/2021–08/2025) and underwent a point‐of‐care, low‐field portable MRI (pMRI) using a 0.064 T scanner (Hyperfine) and pre‐ and post‐scan surveys. For comparison, all participants had received a standard clinical brain MRI of at least 1.5T. Results Of the 130 participants (54% male, 46% female), the mean age was 60.6 years (standard deviation (SD) = 17.5). 71% reported at least one barrier to MRI care. The median interval between pMRI and standard MRI brain imaging was 48.5 days (25th, 75th percentiles: 26, 112.5). Participants rated pMRI as highly tolerable, with 93% reporting comfort scores ≥ 7 (on a 10‐point scale), and 78% indicating willingness to undergo future pMRI. Mean comfort ratings were significantly higher for pMRI (8.4) compared to traditional MRI (7.5; p < 0.05), though the effect size was moderate ( η 2 = 0.096). No differences in tolerability or comfort were observed across disease, age, or sex groups. Common barriers to standard MRI access included transportation, cost, and scheduling, particularly among low‐income or unemployed participants. Qualitative feedback emphasized the need for better physical accommodations but broadly supported the acceptability and potential uses of pMRI. Conclusion These findings support the feasibility, tolerability, and high patient acceptability of pMRI.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Mastick, M. L., Enkhtsetseg, N., Sadok, J., Mochetti, M. M., Sorby‐Adams, A., Guo, J. D., et al. (2026). Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70326

Vancouver

Mastick ML, Enkhtsetseg N, Sadok J, Mochetti MM, Sorby‐Adams A, Guo JD, et al. Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70326. PMID: 41607060.

BibTeX

@article{mastick2026-41607060,
  author  = {Mastick, Maya L and Enkhtsetseg, Nomin and Sadok, Joseph and Mochetti, Matheus Menão and Sorby‐Adams, Annabel and Guo, Jennifer D. and Hacker, Cristina Trapaga and Hjerthen, Isabella Gomez and others},
  title   = {{Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort}},
  journal = {Annals of Clinical and Translational Neurology},
  year    = {2026},
  doi     = {10.1002/acn3.70326},
  pmid    = {41607060},
  url     = {https://doi.org/10.1002/acn3.70326}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This study tested whether a portable, low-field MRI scanner could be used in an outpatient clinic for people with neurological conditions including Alzheimer's-type dementia, and found it was tolerable and acceptable to patients. It is a feasibility study about imaging access and does not test any treatment, cure, or prevention.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 3 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 43 of 100.43 of 100 points earned57 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Annals of Clinical and Translational Neurology)
Journal's citation record 1 / 4 Annals of Clinical and Translational Neurology: journal h-index 97 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 2 / 4 130 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 4.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Farrah Jasmine Mateen: h-index 49 (OpenAlex, whole career)
Institution's track record 3 / 3 Harvard University: institution h-index 3,235 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41607060)
Free to read 2 / 2 Free to read
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Brain scans and imaging

Also tagged “vessel”

900 studies in the library carry the topic tag “vessel”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.

Similar studies

More on Brain scans and imaging

See all studies in Brain scans and imaging →